In conclusion, NLRC5, LCP2, TMEM229B, and FCRL4 were determined to be potential antigens for ESCC mRNA vaccines, possibly more suitable for IS2 patients. This evidence concerns the gene FCRL4 and esophageal squamous cell carcinoma.